FacebookTwitterLinkedin
The American Association of Homeopathic Pharmacists
  • Membership
    • Code of Ethics
    • Committees and Members
    • Join Us
    • Contact
  • About
    • History and Mission
    • Board of Directors
    • AAHP at a Glance
    • What is Homeopathy?
  • Advocacy
    • Compliance
    • Position Statements
    • Regulatory/Legislation
  • Resources
    • Press Releases
    • Articles
    • Webinars
    • Events
    • Academic Resources
    • Consumers
      • FAQs
      • How to Find a Practitioner
      • Other Organizations
  • Member Log In

Event Brochure: Summit On Challenges & Solutions in Quality & Safety of Homeopathic Drug Products

Click here to download the PDF version.

AAHP Summit Brochure - Final1024_1
AAHP Summit Brochure - Final1024_2
AAHP Summit Brochure - Final1024_3
AAHP Summit Brochure - Final1024_4
AAHP Summit Brochure - Final1024_5
AAHP Summit Brochure - Final1024_6
AAHP Summit Brochure - Final1024_7
AAHP Summit Brochure - Final1024_8
AAHP Summit Brochure - Final1024_9
AAHP Summit Brochure - Final1024_10
AAHP Summit Brochure - Final1024_11
AAHP Summit Brochure - Final1024_12

Upcoming Events

  1. 2020 Membership Meeting

    March 6

View All Events

NEWS

  • AAHP 2019: Reawakening the Regulatory and Retail Dialog December 10, 2019 By Mark Land, AAHP President This year marks the fifth year in a cycle of regulatory review of homeopathic drug product labeling, safety, and quality. AAHP has been there for the industry as an advocate and representative over the entire duration. In 2019 AAHP provided direction and regulatory thought-leadership within the homeopathic community, met with FDA’s ...
  • Trump Nominates New FDA Commissioner November 12, 2019 Senate Hearing Set for Nov. 20 By Pete Evich, AAHP Govt. Relations   On Nov. 1, President Trump nominated Stephen Hahn, chief medical executive of the MD Anderson Cancer Center in Houston, to be the next U.S. Food and Drug Administration (FDA) commissioner. If confirmed by the Senate, a process that could take several months, Hahn will take the ...
  • Why It’s Crucial to Monitor FDA Guidances September 11, 2019 By Mark Land, AAHP President It can take several years for manufacturers to implement new guidelines from the Food and Drug Administration (FDA)—and that means they could be at risk in the meantime. However, manufacturers can “get ahead of the game” by monitoring FDA’s guidance development agenda. FDA’s authority to regulate stems from the Federal Food, Drug, ...
OLLOIS
EnergetixLogo
NaturalOphthalmicsLogo
Newsletter SignUp